Cue Biopharma (CUE) Stock: Buy, Sell, or Hold?
$17.50
-1.16 (-6.22%)
âŧ
5d:
-2.83%
30d:
-5.91%
90d:
-48.83%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
44/100
Position
SLIGHTLY LOW
30-Day Fair Range
$17.44 â $22.55
Position: SLIGHTLY LOW
Forward P/E & Valuation
-2.4x
Next 12M consensus est.
Wall Street Target
$88.00
+402.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$16.87 / $21.40
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CUE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CUE is currently trading at $17.50, which is considered slightly low relative to its 30-day fair value range of $17.44 to $22.55.
Technical Outlook: Technically, CUE is in a strong downtrend. Immediate support is located at $16.87, while resistance sits at $21.40. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: CUE scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $88.00 (+402.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CUE is in a strong downtrend. Immediate support is located at $16.87, while resistance sits at $21.40. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: CUE scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $88.00 (+402.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$17.44 -
$22.55
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$17.44 -
$22.55
Current vs Trading Range
SLIGHTLY LOW
Support Level
$16.87
Resistance Level
$21.40
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 402.9% below Wall St target ($88.00)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.35
Wall Street Target
$88.00
(+402.9%)
Revenue Growth (YoY)
166.7%
Share CUE Analysis
Share this live CUE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CUE)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses confidence in $CUE, anticipating a significant price increase. No recent Yahoo Finance news articles are available for analysis.
Key Retail Themes:
bullish sentiment
anticipation of price increase
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:48 PM ET
Data refreshes hourly during market hours. Next update: 7:48 PM
Data refreshes hourly during market hours. Next update: 7:48 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CUE Research Pages
